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Abstract
Group A streptococcus (GAS) causes variety of diseases ranging from common pharyngitis to life-threatening severe invasive
diseases, including necrotizing fasciitis and streptococcal toxic shock-like syndrome. The characteristic of invasive GAS
infections has been thought to attribute to genetic changes in bacteria, however, no clear evidence has shown due to lack
of an intriguingly study using serotype-matched isolates from clinical severe invasive GAS infections. In addition, rare
outbreaks of invasive infections and their distinctive pathology in which infectious foci without neutrophil infiltration
hypothesized us invasive GAS could evade host defense, especially neutrophil functions. Herein we report that a panel of
serotype-matched GAS, which were clinically isolated from severe invasive but not from non-invaive infections, could
abrogate functions of human polymorphnuclear neutrophils (PMN) in at least two independent ways; due to inducing
necrosis to PMN by enhanced production of a pore-forming toxin streptolysin O (SLO) and due to impairment of PMN
migration via digesting interleukin-8, a PMN attracting chemokine, by increased production of a serine protease ScpC.
Expression of genes was upregulated by a loss of repressive function with the mutation of csrS gene in the all emm49 severe
invasive GAS isolates. The csrS mutants from clinical severe invasive GAS isolates exhibited high mortality and disseminated
infection with paucity of neutrophils, a characteristic pathology seen in human invasive GAS infection, in a mouse model.
However, GAS which lack either SLO or ScpC exhibit much less mortality than the csrS-mutated parent invasive GAS isolate
to the infected mice. These results suggest that the abilities of GAS to abrogate PMN functions can determine the onset and
severity of invasive GAS infection.
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Introduction
Streptococcus pyogenes (group A streptococcus; GAS) is one of the most
common human pathogens. It causes a wide variety of infections
ranging from uncomplicated pharyngitis and skin infections to
severe and even life-threatening manifestations, such as necrotiz-
ing fasciitis (NF) and streptococcal toxic shock-like syndrome
(STSS) [1,2], with high mortality rates ranging from 20% to 60%
[3]. Several streptococcal virulence factors, including streptolysin,
and M protein, have been reported to be involved in these
diseases, by genetic studies or animal-passaged models [1,2,4–6].
However, which of factors are involved in pathogenesis mediated
by clinically isolated severe invasive GAS remains obscure.
The strains of emm1 genotype, among more than 100 emm genes
encoding the serotype-determinant M protein, are the predomi-
nant cause of severe GAS infections in Japan [7]. Recently, GAS
with diverse emm genotypes, especially, emm49-genotype, have been
isolated from patients of severe invasive GAS infections since
2000; however, these genotypes were not isolated before 1999 in
Japan [8]. Therefore, emm49 GAS isolated from invasive infections
seems to acquire the novel or altered virulence factors by
mutations, genomic additions, or deletions.
Epidemiological and pathological findings, including sporadic
incidents of severe invasive GAS infections [9], high frequency of
severe invasive infections in immunocompromised host [9], and
aggregation of bacteria and a paucity of polymorphnuclear
neutrophils (PMN) in foci of invasive GAS infection [10] suggest
that host defense factors play an important role in the onset of
invasive infections. These findings led us to postulate that invasive
GAS infections hampered host innate immune defense, especially on
PMN, providing the front-line defense against GAS infection by
quick recruitment to infection site and clearance of bacteria following
phagocytosis [11,12]. So far, using animal-passaged GAS mutants,
gene-manipulated GAS, many virulence-associated molecules are
pointed out to play some roles in the bacterial evasion from
phagocytic ingestion by neutrophils [13]. However, restricted
availability of clinical isolates with the same serotypes fail to elucidate
direct relationship between definitive genetic changes in clinically
isolated severe invasive GAS and the lack of PMN at the site of
bacterial growth.
In the present study, we aimed to explore the crucial factors in
the pathogenesis of severe invasive GAS infections in the context
of PMN-GAS relationship, using a panel of emm49 clinical isolates
from patients with or without severe invasive infection, and their
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unrecognized link between functional loss of a factor CsrS of two-
component sensor/regulator system (CsrS/CsrR: also known as
CovS/CovR) and escape from killing by PMN via inducing
necrosis to them and digesting IL-8, a PMN-attracting chemokine.
We further determined CsrS mutations in the severe invasive GAS
was essential to control the expression of various virulence genes
and contributed to the in vivo virulence and disease-specific
pathophysiology in a mouse model. These data may participate in
prediction of GAS potential for future invasive infection as well as
risk assessment of patients by measuring PMN function.
Results
Group A streptococcus isolates from severe invasive
infections is resistant to killing by human PMN
To examine whether emm49 GAS isolated from severe invasive
infection might alter human PMN function, we performed
phagocytosis assay in vitro. As non-opsonized GAS was resistant to
the phagocytosis by PMN [14], we opsonized GAS with human
plasmainadvancetotheassay.Asshown inFigure1A, therewasno
significant difference between GAS that were isolated from non-
invasive and severe invasive infections in phagocytosis by PMN
(p=0.5556). However, as shown in Figure 1B, in vitro killing assay
revealed that PMN killednon-invasive GAS, resultingin 15–42% of
initial number of bacteria, but not invasive GAS (p=0.019). The
similar results were obtained when opsonized with either FCS or
human serum regardless of complements immobilization (data not
shown). These results were common among all PMN donors. These
data indicated that clinically isolated severe invasive GAS were
phagocytosed, but escaped from killing by human PMN.
Severe invasive GAS rapidly induce necrosis to human
PMN
In an acute bacterial infection, PMN were quickly recruited at the
site of infectious foci according to the gradient of chemoattractants.
Therefore, we examined whether GAS clinically isolated from severe
invasive infections could affect the migration ability of PMN in
response to chemokines. As a model of local infection of the initial
phase, we utilized a transwell system and added IL-8 and GAS in
culture medium within the lower wells. PMN were applied in the
upper wells and subsequently incubated for 90 min. As shown in
Figure 2A and 2B, a substantial number of PMN, consisted largely of
viable cells, was detected in the lower wells consisted of IL-8 and non-
invasive GAS, as a control. Contrarily, number of PMN was
significantly low in the presence of severe invasive GAS (p=0.016)
compared to that of control culture. Flow cytometry analysis
suggested that although PMN was detected in the lower well
consisted of IL-8 and severe invasive GAS, but most of them were
dead as defined by propidium iodine staining (p=0.016) (Figure 2A
and 2C) demonstrating that severe invasive GAS affected survival of
PMN and its migration activity in a transwell system.
PMN were killed by streptolysin O (SLO) from severe
invasive GAS
PMN death was induced shortly after encounter with severe
invasive GAS, and PMN were not in apoptotic death because of low
frequency of cells positive for annexin V (data not shown), which
was seen in the case of cytolysin-dependent cell injury [15]. GAS
produce two cytolysins that may contribute to pathogenesis.
Streptolysin S (SLS) is an oxygen-stable b-hemolysin and Strepto-
lysin O (SLO) is a pore-forming cholesterol-binding toxin [16].
Therefore, to know the mechanism underlying GAS-mediated
killing of PMN, we investigated whether SLO produced by invasive
GAS affect survival of PMN in an in vitro migration assay system.
Figure 3A shows that PMN killing by invasive GAS was blocked
by anti-SLO Ab in culture medium within lower wells of a
transwell system (p=0.018 compared with control Ig), at similar
extent by adding free cholesterol in the medium (data not shown).
Furthermore, an SLO deficient mutant from a STSS isolate
NIH230 (NIH230slo) lost the killing activity for PMN (Figure 3A),
thereby, strongly suggesting that SLO is a key element for PMN
killing mediated by invasive GAS. Contrarily, SLS-deficient
mutant from NIH230 strain (NIH230sagA) killed PMN, as
efficiently as did parent strain, indicating that SLS is dispensable
for killing of PMN mediated by invasive GAS. SLO and SLS
double mutant GAS from NIH230 strain (NIH230slosagA)
displayed the killing activity indistinguishable from that of
NIH230slo, confirming the primarily role of SLO for GAS-
mediated PMN killing. As shown in Figure 3B, incubation of PMN
with supernatant from co-culture of IL-8 and invasive or non-
invasive GAS did not affect PMN viability, suggesting that severe
invasive GAS causes PMN killing following encounter with
bacteria in a contact-dependent manner.
Figure 1. Severe invasive GAS evade killing activity of PMN. (A) Phagocytosis activity of PMN to emm49 GAS. Four non-invasive strains and 5
severe invasive strains labeled with Alexa-488, followed by incubation with PMN at MOI 10 for 60 min. The proportion of GAS-phagocytosed PMN
was then analyzed using flow cytometry. (B) Severe invasive or non-invasive strains were incubated with PMN at MOI 10. After 2 hours, the killing
capacity of PMN was estimated by counting the number of bacteria colonies. The dotted line indicates the number of bacteria applied to the culture.
doi:10.1371/journal.pone.0003455.g001
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we measured SLO hemolytic activity of GAS strains used in this
study. As shown in Figure 3C, SLO activity of severe invasive isolate
NIH230 is increased as twice as that of non-invasive strain 1566
(p=0.017).
Impaired migration of PMN is due to degradation of IL-8
by serine proteinase ScpC
Although NIH230slo lost the killing activity for PMN, migration
of PMN in response to IL-8 in a transwell system was not restored
in the presence of this mutant (Figure 4A), thereby, suggesting that
severe invasive GAS blocks PMN migration by influence on IL-8
activity. Therefore, we quantified the amount of IL-8 in culture
before and after co-culture with clinically isolated GAS or its
mutants. Figure 4B shows that the amount of IL-8 was significantly
reduced by 60-min co-culture with NIH230, as well as NIH230slo,
but not with non-invasive GAS 1556. As previous reports
suggested that the GAS envelope peptidase ScpC (also known as
SpyCEP) degrades the CXC chemokines, such as human IL-8,
Groa, murine KC and MIP-2 [17–19], we established a NIH230
mutant deficient with ScpC (NIH230scpC) and analyzed the
property in a PMN migration assay. The results showed that
NIH230scpC neither digested IL-8, like 1566 strain, (Figure 4B)
nor abrogated the migration of PMN in response to IL-8,
Figure 2. Severe invasive GAS kill human PMN and impair migration ability in response to IL-8. (A) Flow cytometry profiles of migrated
PMN in response to 100 nM IL-8 plus GAS. PMN were applied into the upper well (5610
5 cells) and those migrated into the lower well in a transwell
system in response to IL-8 in the presence of GAS (5610
6 CFU) were stained with propidium iodine and were analyzed using flow cytometry. Each
panel represents migrated PMN encountered with individual clinically isolated GAS strain. The representative data are shown. (B) The proportion of
PMN that migrated into lower wells in response to IL-8, in the presence (closed circles) or absence (open circles) of invasive or non-invasive GAS
strains. Total cell numbers consisted of both viable and dead cells were estimated 60 minutes after incubation. (C) The proportion of live PMN that
migrated into lower wells in response to IL-8 alone (open circles) or IL-8 in the presence of severe invasive or non-invasive GAS strains (closed circles).
Viable cell numbers were analyzed at 60 minutes incubation. *p,0.05 estimated by Mann-Whitney’s U test.
doi:10.1371/journal.pone.0003455.g002
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the migrated PMN as well as the parent strain NIH230 (data not
shown). These results demonstrate that clinically isolated invasive
GAS impaired PMN recruitment and its survival, as a result of
productions of ScpC and SLO, respectively.
Enhanced expression of the slo and the scpC genes in
severe invasive GAS is attributed to mutation of a
transcriptional regulator CsrS
Although sequences of the slo gene and the scpC gene were
identical among clinically isolated non-invasive and severe invasive
GAS (data not shown), Figure 5A shows that the slo and the scpC
genes were expressed in the severe invasive GAS greater in extent
than those in the non-invasive GAS. The expression of the other
virulence-associated genes, such as IgG degrading protease of
GAS, Mac-1-like protein (mac), nicotine adenine dinucleotide
glycohydrolase (nga), polysaccharide capsule production (hasA), and
C5a peptidase (scpA), was also upregulted in the severe invasive
GAS, greater than that detected in the non-invasive GAS
(Figure 5A). Contrarily, the levels of streptococcal pyrogenic
endotoxin (speB), SLS (sagA), and mitogenic factor (speF) genes were
downregulated in the severe invasive GAS, compared to that
found in the non-invasive GAS (Figure 5A and data not shown).
Figure 3. Severe invasive GAS killed PMN bySLO in a contact-dependentmanner. (A) The viability of viable PMN that migrated in lower wells
of transwell system was estimated as Figure 2. To investigate the role of SLO in PMN survival, lower wells consisted of IL-8 in the presence of either
polyclonal rabbit anti-SLO antibodies (25 mg/ml at a final concentration, closed column) or control rabbit IgG (open column), together with either
non-invasive GAS (1566), invasive GAS (NIH230), an csrS-transduced NIH230 (NIH230::csrS+), an SLO deficient NIH230 mutant (NIH230slo), an SLS
deficient NIH230 mutant (NIH230sagA), or SLO and SLS double mutant (NIH230slosagA). Values are mean6SD. *p,0.05 estimated by Student’s t-test.
(B) No substances secreted from GAS reduced PMN viability. PMN was incubated for 2 hours with supernatants from co-culture of IL-8 and invasive or
non-invasive GAS and live cell number was examined as described in Figure 2C. (C). SLO-specific hemolytic activity for sheep erythrocytes in
supernatants from overnight culture of invasive or non-invasive GAS as listed in (A). Forty-five minutes after incubation, the absorbance of culture
supernatants was measured at 540 nm and the SLO-specific hemolytic activity was calculated as described in methods and presented as the
mean6SD. The results represent one of two independent experiments. *p,0.05 significantly higher than non-invasive strain 1566 estimated by
ANOVA. ‘ND’ represents less than 0.5% hemolysis.
doi:10.1371/journal.pone.0003455.g003
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transcriptional profile of several virulence-associated genes,
including the slo and the scpC, in the all severe invasive GAS.
Mutation of csrR or csrS can cause significant alterations in
virulence in mouse models of infection,either increasing lethality
or the severity of localized soft tissue lesions [5,6]. GAS isolates
from mice with severe invasive disease had mutations in csrS,
raising the notion that CsrR/S function is important in
modulating gene expression during infection. Therefore, we
analyzed the linkage between the csrS and/or csrR genes and the
property of invasive GAS infection by sequencing these genes in
the emm49 strains used in this study. The nucleotide sequence of
the csrR gene was identical in all the isolates, and that of the csrS
gene was identical among the all non-invasive GAS isolates (data
not shown). However, as shown in Figure 5B, the csrS genes of all
clinically isolated severe invasive GAS had a deletion, a point
mutation, or an insertion, thereby, resulting in the creation of
translational stop codons (NIH147, NIH226, NIH230, and
NIH269) or in a mutation in the presumed kinase domain
(NIH200). In order to clarify the role of CsrS regarding expression
of the virulence-associated genes and resistance to PMN killing, we
introduced the intact csrS gene of the 1566 strain into the severe
invasive GAS (see Figure 5A). The csrS-introduced severe invasive
GAS reduced the expression levels of the slo and the scpC genes,
comparable to those detected in the non-invasive GAS. In
contrast, the expression of speB was upregulated to the level
observed in the non-invasive GAS (Figure 5A). In parallel with the
expression profile of slo and scpC in the severe invasive GAS,
introduction of the intact csrS gene into the severe invasive GAS
restored the susceptibility to the killing by PMN (p=0.015
compared with severe invasive isolates +CsrS) (Figure 6A),
abrogated the inhibition of PMN migration by degradation of
IL-8 (p=0.002 compared with invasive isolates +CsrS) (Figure 4A,
4B, and 6B), and diminished the killing activity for PMN by
necrosis (p=0.00016 compared with invasive isolates +CsrS)
(Figure 3A, 3C, and 6C), These results strongly suggest that
mutations in the csrS gene correspond to the immunocompro-
mized activity in the severe invasive isolates, associated with
inhibition of PMN recruitment and survival.
csrS mutation is important in the pathogenesis of
invasive infections in a mouse model
In order to elucidate the role of csrS, in infections in vivo,w e
compared the virulence of GAS isolates using a mouse model
which infected GAS intraperitoneally. The non-invasive 1566
strain displayed the LD50 value approximately 100-fold higher
than that of the severe invasive NIH230 strain (Table 1), whereas a
csrS deletion (1566DcsrS) caused an increase in the LD50 value
comparable to that of the NIH230 strain. Consistently, an
introduction of the intact csrS gene into the NIH230 strain
(NIH230::csrS
+) reduced the LD50 value to the level observed in
the non-invasive strain. These results indicate that csrS is an
important virulence factor in the mouse model of lethal infections.
As shown in Figure 7A, the NIH230 strain caused bacteremia in
mice 24 h after intraperitoneal injection whereas the bacteremia
was barely detected in mice infected with NIH230::csrS
+as well as
Figure 4. Severe invasive GAS degrade IL-8 by serine protease ScpC, resulting in impaired PMN migration. (A) Migration abilities of
PMN in response to IL-8 in the presence of non-invasive and invasive GAS, as listed in Figure 3A plus ScpC deficient NIH230 mutant (NIH230scpC).
PMNs that migrated into the lower well in a transwell system were estimated by flow cytometry. (B). IL-8 was added into the culture medium (100 nM
at a final concentration) and incubated with invasive or non-invasive GAS as listed in (A). Sixty minutes after incubation, the amount of IL-8 in
triplicates was measured by sandwich ELISA and presented as the mean6SD. The results represent one of two independent experiments.
doi:10.1371/journal.pone.0003455.g004
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and p=0.005 compared with invasive isolates +CsrS). Histopath-
ologically, in the mice injected with the NIH230 strain, bacteria
formed clusters in interstitial tissues in the kidneys and the lungs,
accompanied congestion and no inflammatory cells at infectious
foci (Figure 7B, 7C and data not shown). Contrarily, no significant
pathological alterations were observed in the mice injected with
the 1566 and NIH230::csrS
+ strains (Figure 7B and 7C). Figure 7D
shows that subcutaneous infection of NIH230 formed the infected
lesions with area significantly larger than those of 1566 and
NIH230::csrS
+. These results suggest that the invasive GAS isolates
are more virulent in vivo than non-invasive GAS, and impair PMN
function in vivo, owing, at least in part, to the mutations in the csrS
gene.
Figure 5. Mutation of the csrS gene in the isolates of the patients with severe invasive infections is responsible for increased
virulence of GAS. (A) Expression of virulence-associated genes in non-invasive and invasive GAS isolates and mutants transduced with csrS,
analyzed by RT-PCR. The expression of virulence-associated factors mRNA: IgG degrading protease of GAS, Mac-1-like protein (mac), nicotine adenine
dinucleotide glycohydrolase (nga), slo, scpC, polysaccharide capsule production (hasA), C5a peptidase (scpA), and streptococcal pyrogenic endotoxin
(speB), plus expression of 16S rRNA (16S) were shown. (B) The csrS mutations in GAS isolates from the patients with severe invasive streptococcal
infections. The numbers at the end of the bars indicate the total amino acid residues of CsrS proteins from the start codon in non-invasive GAS (1566)
and invasive Gas from the patients (NIH147, NIH200, NIH226, NIH230 and NIH 269). Solid boxes represent the newly created amino acids as a result of
frameshift mutations, with length of amino acids ( ‘‘+ number’’ within parentheses). In the NIH200 strain, Ser replaced Gly at position 461 of the CsrS
protein. Type of mutations are listed at the end of bars.
doi:10.1371/journal.pone.0003455.g005
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of invasive infections
Finally, we assessed the influence of enhanced expression of the
scpC or the slo gene on the virulence in a mouse model. As shown in
Table 1, NIH230scpC and NIH230slo exerted the LD50 value 3–10
fold lower than that of the non-invasive isolate 1566, but 10–30 fold
higherthanthatofsevereinvasiveisolates.Subcutaneousinoculation
of NIH230scpC and NIH230slo yielded the local infected lesions with
area comparable to those of 1566 and NIH230::csrS
+ during the
course of infection (Figure 7D). These results suggest that enhanced
expression of ScpC and SLO in invasive GAS plays an important
role in vivo virulence of GAS infection.
Discussion
It have been demonstrated that CsrS/R is a member of the two-
component regulatory systems for regulating the multipe virulence
factors of GAS, by using genetically- manipulated GAS mutants
[20]. The present study demonstrate that the loss-of-functional
mutations in csrS gene which were accumulated in clinically
isolated GAS from patients with severe invasive infections, but not
with emm-matched non-invasive strains. The csrS mutations
enhanced the expression of scpC and slo, associated with the
evasion of PMN functions and in vivo virulence. Introduction of the
intact csrS gene into the severe invasive GAS restored the
susceptibility to the killing by PMN and abrogated the activity
for inhibition of PMN recruitment and survival, thus, demon-
strating an instructional role of the loss-of-functional mutations in
csrS gene for the evasion of PMN functions, providing unique
pathophysiology of invasive GAS infections. Previous studies using
animal-passaged GAS have shown that mutations in both csrS and
csrR gene are important for the invasive phenotype [5,6], and
mutation frequency of csrS and csrR seems to be the same [21].
However, the severe invasive isolates analyzed in this study
accumulated mutations in the csrS gene but not in the csrR gene
(Figure 5B and data not shown). Then we further examined
whether severe invasive isolates of other than emm49 genotype
have the mutation of the csrS and the csrR genes. The frequency of
the mutation in the csrS gene is higher than that in csrR (csrS
mutation:csrR mutation=59:19) (manuscript in preparation),
suggesting the csrS mutation is more important in comparison
with that of csrR in the clinical isolates regardless of emm genotypes.
Furthermore, the expression of some human invasive disease-
Figure 6. Mutations of CsrS is responsible for increased
virulence of GAS to PMN functions. (A) Non-invasive, severe
invasive, and invasive strains with overexpression of CsrS strains were
incubated with PMN at MOI 10. After 2 hours, the number of live
bacteria was counted. The dotted line indicates the number of bacteria
applied to the culture. (B)–(C) CsrS transduction into the invasive GAS
isolates abrogated the killing activity for PMN as well as the inhibitory
effect on PMN migration in a transwell system. (B) The proportion of
PMN consisted of both viable and dead cells and (C) The proportion of
live PMN that migrated into the lower wells in response to IL-8, in the
presence (closed circles) or absence (open circles) of non-invasive GAS,
severe invasive GAS isolates or severe invasive GAS isolates transduced
with CsrS was analyzed at 60 minutes incubation, as described in
Figure. 2B and 2C. *p,0.05 estimated by ANOVA.
doi:10.1371/journal.pone.0003455.g006

















PLoS ONE | www.plosone.org 7 October 2008 | Volume 3 | Issue 10 | e3455Figure 7. Mutations of the csrS, SLO and ScpC regulate in vivo virulence of GAS in a mouse model. (A) Number of GAS organisms
recovered from the blood (100 mL) of each Male ddY mice injected intravenously with 1610
7 CFU in 100 ml suspension of GAS in PBS. Blood was
taken 24 h after injection and the bacterial count was determined after plating on agar. The (-) bar represents median values. *(p,0.05) estimated by
ANOVA. Histopathological changes in the (B) kidney and (C) lungs of mice infected with GAS. Each tissue was extracted 24 h after injecting GAS
(1610
7 CFU). The black arrows indicate clusters of bacteria. (D) The course of subcutaneous infection in hairless mice injected with 1610
7 CFU in
100 mL suspension of GAS in PBS. Lesion area and body weight were measured daily after infection. Values are mean6SEM (n=5). *Area of skin lesion
in NIH230 infected mice was significantly higher than all other groups (p,0.05) estimated by ANOVA.
doi:10.1371/journal.pone.0003455.g007
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(Figure 5B), but not in the csrR mutant [20]. On the contrary of a
dogma that CsrS/R is a definitive member of the two-component
regulatory systems, which involve a coordinate pair of proteins
known as the sensor kinase and the response regulator [20], CsrS
may transmit a signal not only to CsrR but also to other regulators.
This dominant role of CsrS is the first important observation in
this study, and its mutation is possibly more important than that of
csrR in terms of etiopathogenesis of human severe invasive diseases.
Numbers of studies has pointed out virulent factors to evade
host defense using genetically-manipulated GAS and animal
models [18,22,23], although the significance of each factor to
invasive infection is diverse and sometimes controversial, perhaps
due to lack of proper non-invasive counterpart. As examples, SpeB
[22] and SLS [23] have been proposed as an invasive infection-
associated factor by its cytotoxic effect, however, speB and sagA
expression is not enhanced in any csrS-mutated severe invasive
GAS isolate used in this study and others [5,24]. Furthermore,
SLS hemolytic activity of invasive GAS is significantly decreased
as compared with non-invasive strains (data not shown) and SLS-
deletion in invasive GAS did not affect PMN survival at all,
excluding the possibility for the role of SLS in PMN necrosis seen
in this study. Extracellular deoxyribonuclease (DNase) is a
virulence factor that protects emm1 type GAS against neutrophil
killing by degrading the DNA framework of neutrophil extra-
celluar traps (NETs) [25,26]. However, we confirmed that
addition of DNase in the culture did not alter the level of PI-
positive PMN, meaning bright PI staining of PMN is not due to
release of NETs from PMN (Figure S1A). DNase activity of the
emm49 severe invasive GAS was lower than that of non-invasive
GAS (Figure S1B), possibly due to the difference of emm type. The
expression of DNase as well as the slo and the scpC genes in emm1-
genotype strains was enhanced under the csrS mutation [5]. These
suggest that DNase may be important but redundant for induction
of invasive diseases. Therefore, the second important observation
in the present study is that an essential requirement of csrS
mutation for invasive infection is associated with increased
expression of ScpC and SLO and in vitro evasion of PMN
functions, though we do not exclude the possibility that other
CsrS-regulating factors contribute to the escape of invasive GAS
from host defense.
SLO and ScpC independently enable GAS to escape from
PMN functions; Present data using clinical isolated GAS and a
scpC-deletion mutant (Figure 4A and 4B) show that enhanced
production of serine proteinase ScpC in virulent GAS is essential
to impair PMN migration in vitro by degradation of IL-8, as others
partially have demonstrated [17–19]. The present study also
uncovers that increased activity of SLO from invasive GAS isolates
induces rapid and extensive necrosis to human PMN. SLO is a
cholesterol-binding pore-forming hemolysin as well as cytotoxic
for other cells [15]. A study has demonstrated SLO from invasive
GAS lyse PMN [27], however this effect is likely due to
complement activation by SLO [28] or PMN activation [29] but
not due to cytotoxity of SLO itself as judged by their flow
cytometry profiles which are distinct from ours (Figure 2A). In the
present study, we observed that SLO concentration in a short-time
culture with severe invasive GAS did not reach the threshold level
to kill PMN by formation of pores (data not shown) and that PMN
did not undergo necrosis upon incubation with culture media of
severe invasive GAS (Figure 3B), leading to the novel possibility
that PMN are probably killed following encounter with invasive
GAS in a contact-dependent manner. PMN-binding GAS may
make a small interface containing a high concentration of SLO
between bacteria and PMN, which resembles to killing mechanism
of killer cells to target cells [30]. Collaboration of SLO with other
toxins may be critical to induce PMN necrosis as similarly
mechanism has been reported [31], although it remains to be
examined whether there exist explore interaction-associated
molecules on both host and bacterial membrane is needed.
In contrast to the previous view [18], we observed that both of
ScpC and SLO together, but not each of them, mediated sufficient
in vivo virulence (Table 1), thus compatible with the notion that
plural virulence-associated factors under the regulation of csrS
abrogate PMN bactericidal functions and induce invasive diseases
in in vivo animal model. Consistently, the high mortality and
histopathological findings which lacks PMN infiltration in mice
tissues infected with csrS-mutated GAS (Figure 7) are similar to
those seen in clinical invasive GAS infections [32]. Thus, these
results suggest that the ability of incompetence for PMN functions
by individual GAS strain may determine the induction and clinical
outcome of invasive diseases. Several clinical reports seem to
support this hypothesis; Leukocytopenia seen in patients with
STSS is more severe than that with non-STSS [33], and invasive
GAS-infected patients with leukocytopenia show worse prognosis
than those without leukocytopenia [33,34]. Furthermore, predis-
posing factors for severe invasive GAS infection [9], such as
diabetes mellitus [35], liver cirrhosis [36], and congestive heart
failure [37] are known to impair PMN function. These evidences
suggest that the level of PMN function is one of the critical factors
to determine the threshold for the onset of invasive GAS infection,
which may be the reason for rare outbreaks of invasive GAS
infections.
Thus, enhanced expression of virulence factors that could evade
PMN function is a key issue at first step to cause invasive bacterial
infections. A further study in which collates clinical with bacterial/
immunological data may provide with novel clues for early
diagnosis and therapeutics of invasive bacterial infections.
Methods
Bacterial strains and culture
The S. pyogenes strains used in this study are described in Table
S1 [8,38]. Escherichia coli DH5a was used as the host for plasmid
construction and was grown in liquid Luria-Bertani medium with
shaking or on agar plates at 37uC. S. pyogenes was cultured in Todd-
Hewitt broth supplemented with 0.5% yeast extract (THY
medium) without agitation or on tryptic soy agar supplemented
with 5% sheep blood. Cultures were grown at 37uC in a 5% CO2
atmosphere. When required, antibiotics were added to the
medium at the following final concentrations: erythromycin,
500 mg/mL for E. coli and 1 mg/mL for S. pyogenes; spectinomycin
(Sp), 25 mg/mL for E. coli and S. pyogenes both. The growth of S.
pyogenes was turbidimetrically monitored at 600 nm using Mini-
Photo 518R (Taitec, Tokyo, Japan).
Animals
Male 5–6-week-old outbred ddY and hairless mice were
purchased from SLC (Shizuoka, Japan) and were maintained in
a specific pathogen-free (SPF) condition. All animal experiments
were performed according to the guidelines of the Ethics Review
Committee of Animal Experiments of the National Institute of
Infectious Diseases, Japan.
Isolation of human PMN
PMN were taken from nine healthy volunteers which were
composed of 25–52 years old, 7 males and 2 female, and were
isolated from venous blood of them using in accordance with a
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Subjects, National Institute of Infectious Diseases.
DNA manipulation
DNA amplifications by PCR, DNA restriction-endonuclease
digestions, ligations, plasmid preparations, and agarose gel
electrophoresis were performed according to standard techniques
[42]. PCR reactions were performed using TaKaRa Ex Taq
(TaKaRa Bio, Tokyo, Japan). Nucleotide sequence was deter-
mined by using the automated sequencer ABI PRISM 3100
Genetic Analyzer (Applied Biosystems, Tokyo, Japan)
Transformation
Calcium chloride (CaCl2) competent E. coli cells were prepared
and transformed according to a standard protocol [39]. Electro-
competent S. pyogenes cells were prepared as described [38].
Construction of deletion or deficient mutants
(i) Construction of the csrS mutants. A 1002-bp DNA
fragment containing the 59 terminal of csrS and the
adjacent upstream chromosomal DNA was amplified from
the 1566 chromosomal DNA using the primers for csrSdel1
and csrSdel2 (Table S2), and a 1104-bp fragment containing
the 39 terminal of csrS and the adjacent downstream
chromosomal DNA was amplified from the NIH230
chromosomal DNA using the primers for csrSdel3 and
csrS4del4 (Table S2); these 2 PCR products were ligated by
BamHI and EcoRI and by EcoRI and PstI, respectively. The
digested fragments were cloned into the erythromycin-
resistant and temperature-sensitive shuttle vector pJRS233
[40] in order to create the plasmid pJRSDcsrS. This
plasmid was then purified from E. coli and introduced into
the strains NIH230 and 1566 by electroporation. The
transformants were selected by observing the growth on
erythromycin agar at 30uC. The cells in which pJRSDcsrS
had been integrated into the chromosome were selected by
the growth of the transformants at 39uC with erythromycin
selection. The plasmid-integrated strain was serially
passaged in a liquid culture at 30uC without erythromycin
selection in order to facilitate the excision of the plasmid
and thus, leaving the desired mutation in the chromosome.
The replacement of the native csrS gene by the csrS-deleted
mutant allele was verified by PCR, and the resultant strains
were named as NIH230DcsrS and 1566DcsrS, respectively.
(ii) Construction of the slo mutant. A 1061-bp DNA
fragment containing the internal region of slo was
amplified from the NIH230 chromosomal DNA using
the primers for slo-del3 and slo-del4 (Table S2). The PCR
products were ligated by BamHI and EcoRI. This
fragment was then cloned into the integration shuttle
vector pSF152 [41] to create the plasmid pSF152slo that
was then used for the chromosomal inactivation of the slo
gene, as described previously [40]. The inactivated
mutant strain NIH230slo (slo::aad9 Sp
r) was then selected
by using spectinomycin-containing agar plates. Deficien-
cy of the native slo gene was verified by PCR. Loss of SL
hemoltitic activity of these mutants was confirmed by the
standard SLS hemolysis assay (Figure 3C).
(iii) Construction of the sagA mutants. A 635-bp DNA fragment
containing the 59 terminal of sagA and the adjacent
upstream chromosomal DNA was amplified from the
NIH230 chromosomal DNA using the primers for sagA0-
Xb and sagA2-Bm (Table S2) and a 1037-bp fragment
containing the 39 terminal of sagA and the adjacent
downstream chromosomal DNA was amplified from the
NIH230 chromosomal DNA using the primers for sagA3-
Bm and sagA4-Ps; these 2 PCR products were ligated by
XbaI and BamHI and by BamHI and PstI, respectively. The
digested fragments were then cloned into the temperature-
sensitive shuttle vector pJRS233 to create the plasmid
pJRSDsagA that was then used to create NIH230DsagA, as
described above. Loss of SLS hemoltitic activity of these
mutants was confirmed by the standard SLS hemolysis
assay.
(iv) Construction of the scpC mutant. A 1240-bp DNA
fragment containing the internal region of scpC was
amplified from the NIH230 chromosomal DNA using
the primers for scpC-del5 and scpC-del6 (Table S2). The
PCR products were ligated by BamHI and EcoRI. This
fragment was then cloned into the integration shuttle
vector pSF152 [41] to create the plasmid pSF152scpC that
was then used to create NIH230scpC, as described above.
Construction of the strains integrating the intact csrS
gene
The csrS gene replacement was performed by allelic recombi-
nation. Specifically, the chromosomal DNA derived from the GAS
strain 1566 was purified and used as a template for the PCR
amplification of the csrS gene. The primers used were 59-
GGGGATCCTGAGATTCCTCTCACTAAAC-39 (sense) and
59-GGGAATTCTCTAATACACTATTTTACC-39 (antisense).
The PCR fragment was ligated into the plasmid pSF152 [41],
and the resultant plasmid pSFcsrS was used for chromosomal
integration into the mutated csrS gene of isolates from patients of
severe invasive infections, as described previously [41]. The
integrated strains (Sp
r) were then selected by using spectinomycin
(Sp)-containing agar plates. The integration of the csrS gene was
confirmed by PCR.
RT-PCR
S. pyogenes was grown in THY media at 37uC without aeration,
and total RNA was extracted at OD600 of 0.75 by using the
RNeasy Mini extraction kit (Qiagen). RT-PCR was performed by
using a One Step RNA PCR Kit (AMV) (TaKaRa Shuzo Co.,
Kyoto, Japan) according to the manufacturer’s recommendation
using the RT-PCR primer pairs shown in Table S3.
GAS infection in a mouse model
To determine LD50, We injected several dilutions of 0.5 mL of
GAS isolate suspensions in phosphate-buffered saline (PBS)
intraperitoneally into male 5–6-week-old ddY outbred mice (5
mice/dilution, 9 dilutions for each GAS isolate). The exact
numbers of the colony-forming units of the injected bacteria were
determined by incubating adequate dilutions of each GAS sample
on sheep blood agar plates. The data were analyzed for
significance according to the Probit method to determine the
LD50 values for a 7-day period. For a subcutaneous infection
model, male hairless mice Hos:Hr-1 were injected 1610
7 CFU in
100 ml suspension of GAS in PBS. Lesion area and body weight
were measured daily, and analyzed
Histopathology
For histological analysis, the tissues from GAS-infected mice
were fixed in 10% formalin/PBS. The paraffin-embedded sections
were stained with hematoxylin and eosin (Sapporo General
Pathology Laboratory Co. Ltd., Hokkaido, Japan).
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Phagocytosis and killing assay by PMN were performed as
previously described with some modifications [14]. 5610
5 human
PMN and 5610
6 bacteria opsonized with human plasma and
labeled with alexa 488 (Invitrogen, Carlsbad, CA) in a well of 24
well plates. After incubation for 60 min, PMN were harvested and
stained with alexa-594 labeled anti-alexa 488 polyclonal Ab
(Invitrogen) in order to distinguish non-phagocytosed but attached
bacteria to PMN. The proportion of phagocytosed PMN were
analyzed by FACS Calibur (BD Biosciences, San Jose, CA), For
killing assay, PMN and opsonized bacteria in the same MOI as
phagocytosis assay were incubated for 2 hours at 37uC, adding
antibiotics at 60 min to eliminate non-phagocytosed bacteria.
Corrected PMN were lysed in 0.1% saponin / PBS for 20 min on
ice. Bacteria were washed with PBS and cultured on soy beans
agar plate overnight, for counting the number of colonies.
Migration assay
Chemotaxis assay were performed as previously described with
modification [42]. Briefly, 5610
5 PMN in RPMI medium
containing 25 mM HEPES and 1% FCS were in Transwell
inserts (3 mm pore size, Coaster, Corning, NY) placed in 24-well
plates containing 600 ml medium, or 100 nM IL-8 solution
(Peprtec, London, UK), which were incubated with or without
5610
6 bacteria for 1 hour at 37uC in advance of the assay. After
1 hour incubation, cells in the lower wells were collected and 10
4
10 mm microsphere beads (Polysciences Inc., Warrington, MA)
were added. Cells were stained with propidium iodine (Sigma, St
Louis, MI) for flow cytometry to quantify viable PMN and were
analyzed using FACSCalibur. In some experiments, cholesterol
(Sigma), 25 mg/mL anti-SLO polyclonal Ab (American Research
Product, Inc., Belmont, MA), or rabbit IgG was added in 24 well
plates.
ELISA
The amount of IL-8 in supernatant after incubation with bacteria
was determined by Ready-to-Go human IL-8 ELISA kit
(eBioScience, San, Diego, CA) according to manufacturers’ protocol.
SLO-hemolysis assay
The activity of SLO in supernatant is measured as previously
described [43]. Briefly, overnight culture supernatants of various
strains were subjected to centrifugation, and were filtrated through
a 0.45 mm membrane. Dithiothreitol and trypan blue were then
added to each sample to a final concentration of 4 mM and
13 mg/mL respectively, and the mixtures were incubated at room
temperature for 10 min. A 0.2 ml aliquot of 5% (v/v) sheep
erythrocyte in PBS was added to 0.4 ml of each treated sample.
After 30 min incubation at 37uC, the mixtures were subjected to
centrifugation, and absorbance of the supernatants fluids was
measured at 540 nm. To confirm that hemolysis was due to SLO,
control reaction including culture supernatants to which water-
soluble cholesterol (Sigma), a specific SLO inhibitor, had been
added to yield a final concentration of 250 mg/mL.
SLS-hemolytic assay
Overnight culture of various strains were frozen at 280uC,
thawed, and centrifuged to obtain the supernatants. Serially
diluted culture supernatants (0.1 ml) in PBS containing 250 mg/
mL water-soluble cholesterol were incubated at room temperature
for 10 min. A 0.1 ml aliquot of 5% (v/v) sheep erythrocyte was
added and incubated for 1 h at 37uC. The mixture were subjected
to brief centrifugation, and absorbance of the supernatants fluids
was measured at 540 nm. To confirm that hemolysis was due to
SLS, control reaction including culture supernatants to which
trypan blue (Sigma), a specific SLS inhibitor, had been added to
yield a final concentration of 13 mg/ml.
Supporting Information
Figure S1 DNase activity is not involved in the virulence of
emm49 severe invasive GAS isolates. a) To investigate the role of
DNase in PMN survival, the viability of PMN that migrated in
lower wells of transwell system was estimated as PMNs were
applied into the upper well (56105 cells) of a transwell system, and
lower wells consisted of IL-8 in the presence or absence of DNase I
(100 mg/ml at a final concentration), together with either non-
invasive GAS (1566), or invasive GAS (NIH230). PMN migrated
in lower wells were stained with propidium iodine and were
analyzed using flow cytometry. b) Activity of DNase in emm49
GAS. 10 ng of Calf thymus DNA was incubated with or without
culture supernatants from non-invasive, severe invasive, and CsrS-
transduced severe invasive GAS for 15 min at 37uC. Activity to
degrade calf thymus DNA was visualized by 1% agarose gel
electrophoresis. Methods in vitro migration assay As shown 56105
PMN in RPMI medium containing 25 mM HEPES and 1% FCS
were in Transwell inserts (3 mm pore size, Coaster) placed in 24-
well plates containing 600 ml medium, 100 nM IL-8 solution
(Peprtec), 100 mg/mL deoxyribonuclease I (Sigma, St Louis, MI)
which were incubated with or without 56106 bacteria for 1 hour
at 37uC in advance of the assay. After 1 hour incubation, cells in
the lower wells were collected and 104 10 mm microsphere beads
(Polysciences) were added. Cells were stained with propidium
iodine (Sigma) for flow cytometry to quantify viable PMN and
were analyzed using FACSCalibur (BD BioScience). DNase
activity assays Supernatants were collected from overnight cultures
of bacterial strains grown in THB. Calf thymus DNA (10 ng) was
combined with bacterial supernatant in final volume of 50 ml
buffer (300 mM Tris-HCl (pH 7.5), 3 mM CaCl2, 3 mM MgCl2)
for 15 min at 37uC. To halt DNase activity, 10 ml of 0.5 M
EDTA (pH 8.0) was added to the reaction. Visualization of DNA
degrad tion was done in 1% agarose gel electrophoresis.
Found at: doi:10.1371/journal.pone.0003455.s001 (0.60 MB TIF)
Table S1 Strains and plasmids used in this study
Found at: doi:10.1371/journal.pone.0003455.s002 (0.03 MB
DOC)
Table S2 Primers used for the construction of deletion mutants
Found at: doi:10.1371/journal.pone.0003455.s003 (0.03 MB
DOC)
Table S3 Primers used in RT-PCR
Found at: doi:10.1371/journal.pone.0003455.s004 (0.03 MB
DOC)
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